123 related articles for article (PubMed ID: 31220406)
21. Small Heat Shock Proteins B1 and B6: Which One is the Most Effective Adjuvant in Therapeutic HPV Vaccine?
Bolhassani A; Shahbazi S; Milani A; Nadji SA
IUBMB Life; 2018 Oct; 70(10):1002-1011. PubMed ID: 30171788
[TBL] [Abstract][Full Text] [Related]
22. Development of HCV Therapeutic Vaccines Using Hp91 Peptide and Small Heat Shock Protein 20 as an Adjuvant.
Basirnejad M; Bolhassani A
Protein Pept Lett; 2018; 25(10):924-932. PubMed ID: 30255740
[TBL] [Abstract][Full Text] [Related]
23. Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates.
Hadi A; Rastgoo A; Eskandarian M; Haghighipour N; Bolhassani A
J Immunol Res; 2021; 2021():5538348. PubMed ID: 33997055
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Adjuvant Effects of Montanide ISA-720 and Heat Shock Protein 27 in Increasing Immunostimulatory Properties of HIV-1 Nef-Vif Fusion Protein Construct.
Khairkhah N; Shahhosseini F; Agi E; Milani A; Bolhassani A
Protein Pept Lett; 2023; 30(5):401-410. PubMed ID: 37016523
[TBL] [Abstract][Full Text] [Related]
25. Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations.
Milani A; Akbari E; Pordanjani PM; Jamshidi F; Ghayoumi S; Sadeghi SA; Bolhassani A
HIV Med; 2024 Feb; 25(2):276-290. PubMed ID: 37936563
[TBL] [Abstract][Full Text] [Related]
26. The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model.
Mehrlatifan S; Mirnurollahi SM; Motevalli F; Rahimi P; Soleymani S; Bolhassani A
Drug Deliv; 2016 Oct; 23(8):2852-2859. PubMed ID: 26559939
[TBL] [Abstract][Full Text] [Related]
27. Delivery of HIV-1 Nef linked to heat shock protein 27 using a cationic polymer is more effective than cationic lipid in mammalian cells.
Milani A; Bolhassani A; Heshmati M
Bratisl Lek Listy; 2017; 118(6):334-338. PubMed ID: 28664742
[TBL] [Abstract][Full Text] [Related]
28. Engineered dendritic cells-derived exosomes harboring HIV-1 Nef
Pordanjani PM; Bolhassani A; Pouriayevali MH; Milani A; Rezaei F
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132236. PubMed ID: 38768924
[TBL] [Abstract][Full Text] [Related]
29. Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects.
Sadeghi L; Bolhassani A; Mohit E; Baesi K; Aghasadeghi MR
Curr HIV Res; 2024 May; ():. PubMed ID: 38712371
[TBL] [Abstract][Full Text] [Related]
30. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
[TBL] [Abstract][Full Text] [Related]
31. Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes.
Milani A; Agi E; Hassan Pouriayevali M; Motamedi-Rad M; Motevalli F; Bolhassani A
Int Immunopharmacol; 2022 Dec; 113(Pt A):109406. PubMed ID: 36461600
[TBL] [Abstract][Full Text] [Related]
32. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
33. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
[TBL] [Abstract][Full Text] [Related]
34. Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: A preliminary study.
Rostami H; Ebtekar M; Ardestani MS; Yazdi MH; Mahdavi M
Immunol Lett; 2017 Jul; 187():19-26. PubMed ID: 28479111
[TBL] [Abstract][Full Text] [Related]
35. MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
Saleh T; Bolhassani A; Shojaosadati SA; Aghasadeghi MR
Vaccine; 2015 Jun; 33(28):3164-70. PubMed ID: 26001433
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 p24-nef DNA Vaccine Plus Protein Boost Expands T-Cell Responses in BALB/c.
Larijani MS; Sadat SM; Bolhassani A; Khodaie A; Pouriayevali MH; Ramezani A
Curr Drug Deliv; 2021; 18(7):1014-1021. PubMed ID: 33388019
[TBL] [Abstract][Full Text] [Related]
37. ELISPOT analysis of a new CTL based DNA vaccine for HIV-1 using GM-CSF in DNA prime/peptide boost strategy: GM-CSF induced long-lived memory responses.
Mahdavi M; Ebtekar M; Khorram Khorshid HR; Azadmanesh K; Hartoonian C; Hassan ZM
Immunol Lett; 2011 Oct; 140(1-2):14-20. PubMed ID: 21679728
[TBL] [Abstract][Full Text] [Related]
38. A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.
Vijayan A; García-Arriaza J; Raman SC; Conesa JJ; Chichón FJ; Santiago C; Sorzano CÓ; Carrascosa JL; Esteban M
PLoS One; 2015; 10(7):e0133595. PubMed ID: 26208356
[TBL] [Abstract][Full Text] [Related]
39. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
[TBL] [Abstract][Full Text] [Related]
40. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
